Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Cutan Med Surg ; 23(4): 370-379, 2019.
Article in English | MEDLINE | ID: mdl-31010295

ABSTRACT

BACKGROUND: 5-aminolevulinic acid photodynamic therapy (PDT) for genital warts is effective, safe, and can prevent recurrence. It is believed that PDT can induce immune responses, but the mechanism is not completely understood. OBJECTIVES: The objectives of this article are to confirm the effect of PDT for genital warts on local immunity and to investigate the recruitment and significance of immune cells in tissues. METHODS: Local immune changes in T lymphocytes (CD3+, CD4+, CD8+), plasmacytoid dendritic cells (pDCs) (CD123+), and myeloid dendritic cells (CD1a+) after PDT in patients were evaluated by immunohistochemistry staining. Changes in mRNA levels of IFN-γ, IFN-α, IFN-ß, interferon-stimulated gene 15 kDa (ISG-15), Mx2, Toll-like receptor 9 (TLR9), and interferon regulatory factor 7 (IRF7) were analyzed by real-time quantitative polymerase chain reaction. RESULTS: At 4 hours after PDT, CD4+ increased, accompanied by increased levels of mRNA expression of IFN-γ, but CD4+ and mRNA expression levels of IFN-γ were decreased at 24 hours after PDT. CD123+ pDCs showed an increasing trend. CD1a+ LCs in the epidermis gradually decreased, and DCs in the epidermis gradually increased. CD3+ infiltrated and migrated to the superficial dermis, but CD8+ did not change significantly after PDT. The mRNA expression levels of IFN-α, IFN-ß, ISG-15, Mx2, TLR9, and IRF7 showed an increasing trend after PDT. As compared with the patients without significantly increased IFN-α and IFN-ß after PDT sessions, patients with significant increases needed fewer sessions of PDT for remission. CONCLUSIONS: PDT for genital warts can activate T lymphocyte-mediated, DC-related, and pDC-related immunity. The clinical efficacy of PDT for genital warts may be related to the increased levels of IFN-α and IFN-ß after treatment.


Subject(s)
Aminolevulinic Acid/pharmacology , Condylomata Acuminata/drug therapy , Epidermis/immunology , Langerhans Cells/immunology , Photochemotherapy , Photosensitizing Agents/pharmacology , Adult , Aminolevulinic Acid/therapeutic use , Antigens, CD1/metabolism , CD3 Complex/metabolism , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/immunology , Cytokines/genetics , Epidermis/metabolism , Female , Gene Expression/drug effects , Humans , Interferon Regulatory Factor-7/genetics , Interferon-alpha/genetics , Interferon-beta/genetics , Interferon-gamma/genetics , Interleukin-3 Receptor alpha Subunit/metabolism , Langerhans Cells/drug effects , Langerhans Cells/metabolism , Male , Middle Aged , Myxovirus Resistance Proteins/genetics , Photosensitizing Agents/therapeutic use , RNA, Messenger/metabolism , Toll-Like Receptor 9/genetics , Ubiquitins/genetics , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...